TARGETEVALUATOR Trademark

Trademark Overview


On Friday, December 8, 2000, a trademark application was filed for TARGETEVALUATOR with the United States Patent and Trademark Office. The USPTO has given the TARGETEVALUATOR trademark a serial number of 78038447. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Saturday, August 16, 2008. This trademark is owned by PHARMAGENE LABORATORIES LIMITED. The TARGETEVALUATOR trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Drug discovery services; pharmaceutical research services; pre-clinical screening, and clinical research and evaluation services; bioinformatics, genomics, proteomics and pharmacology research services; development of human disease models for use in evaluation of drugs and discovery of new drugs; drug discovery, drug screening, pre-clinical, and pharmaceutical programs; compilation of databases for use in pharmaceutical research; compilation of databases for use in research into human gene and human protein functions; design of computer models for use in pre-clinical, clinical and pharmaceutical research; collection and maintenance of data for study of genomes; collection and maintenance of genetic information including gene form and gene function; consultancy, information and advisory services for to all the aforesaid services

General Information


Serial Number78038447
Word MarkTARGETEVALUATOR
Filing DateFriday, December 8, 2000
Status710 - CANCELLED - SECTION 8
Status DateSaturday, August 16, 2008
Registration Number2507239
Registration DateTuesday, November 13, 2001
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, August 21, 2001

Trademark Statements


Goods and ServicesDrug discovery services; pharmaceutical research services; pre-clinical screening, and clinical research and evaluation services; bioinformatics, genomics, proteomics and pharmacology research services; development of human disease models for use in evaluation of drugs and discovery of new drugs; drug discovery, drug screening, pre-clinical, and pharmaceutical programs; compilation of databases for use in pharmaceutical research; compilation of databases for use in research into human gene and human protein functions; design of computer models for use in pre-clinical, clinical and pharmaceutical research; collection and maintenance of data for study of genomes; collection and maintenance of genetic information including gene form and gene function; consultancy, information and advisory services for to all the aforesaid services

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateSaturday, August 16, 2008
Primary Code042
First Use Anywhere DateSaturday, August 12, 2000
First Use In Commerce DateSaturday, August 12, 2000

Trademark Owner History


Party NamePHARMAGENE LABORATORIES LIMITED
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressROYSTON, HERTFORDSHIRE SG8 5HD
GB

Party NamePHARMAGENE LABORATORIES LIMITED
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressROYSTON, HERTFORDSHIRE SG8 5HD
GB

Party NamePHARMAGENE LABORATORIES LIMITED
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressROYSTON, HERTFORDSHIRE SG8 5HD
GB

Trademark Events


Event DateEvent Description
Saturday, August 16, 2008CANCELLED SEC. 8 (6-YR)
Friday, January 12, 2007CASE FILE IN TICRS
Wednesday, January 22, 2003TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 13, 2001REGISTERED-PRINCIPAL REGISTER
Tuesday, August 21, 2001PUBLISHED FOR OPPOSITION
Wednesday, August 1, 2001NOTICE OF PUBLICATION
Friday, May 18, 2001APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 1, 2001ASSIGNED TO EXAMINER